Genetic fusion of protein-encoding genes of interest is the most common method for the production of chimeric proteins. Although the genetic engineering required to produce such fusions is straightforward, the resulting product may not express or fold properly, with consequent loss of function. Sortase Acatalyzed transacylation reactions 3-5 can prevent such pitfalls and covalently link two already correctly folded proteins. In this strategy, the N terminus of one of the proteins of interest is equipped with an oligoglycine sequence, whereas the C terminus of the other protein is engineered with an LPXTG sortase recognition motif. Sortase A from Staphylococcus aureus cleaves the LPXTG sequence between the threonine and the glycine residues to yield an acyl-enzyme intermediate. The protein with an N-terminal oligoglycine sequence can act as a nucleophile and resolve the acyl-enzyme intermediate to create the fusion protein.
IntroDuctIon
Chimeric proteins are useful research tools that have interesting therapeutic possibilities as well. Fusing a protein of interest with a fluorescent protein, such as GFP, allows the study of its intracellular localization and trafficking 1 . Fusions of toxins with cytokines or antibodies have been used to yield effective cancer treatments 2 .
Genetic fusion of protein-encoding genes of interest is the most common method for the production of chimeric proteins. Although the genetic engineering required to produce such fusions is straightforward, the resulting product may not express or fold properly, with consequent loss of function. Sortase Acatalyzed transacylation reactions [3] [4] [5] can prevent such pitfalls and covalently link two already correctly folded proteins. In this strategy, the N terminus of one of the proteins of interest is equipped with an oligoglycine sequence, whereas the C terminus of the other protein is engineered with an LPXTG sortase recognition motif. Sortase A from Staphylococcus aureus cleaves the LPXTG sequence between the threonine and the glycine residues to yield an acyl-enzyme intermediate. The protein with an N-terminal oligoglycine sequence can act as a nucleophile and resolve the acyl-enzyme intermediate to create the fusion protein.
(For detailed information on sortase A, the reaction and references, see Guimaraes et al. 6 .) This strategy is site specific and versatile and has been used to prepare a wide array of protein fusions [7] [8] [9] [10] .
However, many proteins, including antibodies, require one of their termini to remain unmodified for retention of activity. Thus, a standard genetic fusion of two proteins of this type would diminish or abolish the activity of one of the proteins. Sortasemediated reactions and similar conjugation strategies, such as intein chemistry 11 , split intein 12 and native chemical ligation 13 exclusively afford N-to-C and C-to-N fused proteins, but fusing proteins that require one of their termini for activity using these techniques would result in a similar loss of activity. In these cases, a fusion of the same termini (i.e., N-to-N or C-to-C) might be preferable. To create fusions of this kind, one has to resort to chemical linking strategies using cross-linkers, such as bismaleimide linkers. The functional groups of cysteine and lysine residues of antibodies have successfully been linked, producing bispecific antibodies 14, 15 , but these methods are not very selective. Several bioorthogonal reactions such as the copper-catalyzed click reaction or the strain-promoted click reaction are selective, but the required reaction handles still need to be introduced in the protein 16 . This protocol describes a straightforward procedure for site-selectively introducing click handles at the N terminus or C terminus of a protein using sortase A-catalyzed transacylation. Strain-promoted click reaction of the resulting click handlecontaining proteins allows production of unnaturally linked proteins ( Fig. 1) 17 . This protocol elaborates on the protocols that describe C-terminal 6 and N-terminal labeling 18 using sortase A and is complentary to these protocols in that unnaturally N-to-N and C-to-C linked fusion proteins can be prepared. The advantage of this protocol is that correctly folded proteins are equipped with a click handle, which circumvents folding issues encountered during expression of genetic fusions. Preparation of a variety of click handle-containing proteins allows facile mix-and-match click ligations. A limitation of the cyclooctynes used in the described protocol is that nonspecific fusion/ oligomerization of cysteine-rich proteins may be observed as a result of thio-yne reactions 19 .
Synthesis of the click handle-containing peptide probes. Peptides for creating C-to-C linked proteins (1) (2) (3) are synthesized with an N-terminal triglycine motif and an azide or cyclooctyne (DIBAC) 20 at the C terminus (Fig. 2) . Although the azido group is stable both under basic and acidic conditions and can be introduced in the course of synthesis on a solid support, the DIBAC is labile under strong acidic and alkaline conditions 20 and is best introduced after cleaving the peptide from the resin. The azido group can thus be introduced on the resin by coupling Fmoc-azidolysine-OH or by modifying a lysine side chain with azidohexanoic acid. The DIBAC group must be introduced after cleaving the peptide off the resin, using cysteine maleimide chemistry to selectively link the cyclooctyne in the presence of a free N terminus. A fluorescent dye, such as the TAMRA group in peptide 1, can be incorporated for visualization purposes.
To prepare N-to-N linked proteins, we synthesize peptides containing the LPXTGG sortase A recognition sequence at the C terminus (X can be any residue, but we prefer a polar residue, such as a glutamic acid, to aid precipitation of the peptide after cleavage from the resin and to increase the solubility of the peptide in water) and an azido or a cyclooctyne 20 group at the N terminus of the probe (4 and 5) (Fig. 2) . Again, the azido group is introduced on the resin, whereas the cyclooctyne is introduced after the peptide is synthesized by using solid-phase peptide synthesis and then cleaved from the resin.
Preparation of sortase A and protein substrates. The preparation of sortase A from S. aureus and the design of proteins containing a sortase A recognition sequence is described in detail in Guimaraes et al. 6 and in Theile et al. 18 . Here we provide a brief strategy and some considerations for the design of proteins to be used in the synthesis of N-to-N and C-to-C fused proteins. Proteins that require the N terminus for activity must be sortagged via the C terminus with a click handle. By using standard molecular cloning techniques, the protein of interest is engineered with a C-terminal LPXTG sequence followed by an optional His tag. The His tag is lost in the course of the sortase reaction and simplifies analysis of the sortase-catalyzed transacylation of the click probe and purification of the modified protein. Both sortase A and the unreacted input substrate remain His-tagged, and they can be removed from the final reaction mixture by adsorption onto Ni-NTA agarose. For fusion proteins that require free C termini for their function, the click handles are introduced at the N terminus. For this purpose, one to five glycine residues are engineered at the N terminus of the protein via standard molecular cloning techniques. The accessibility of the N-terminal oligoglycine sequence and of the C-terminal LPXTG motif has a marked influence on the reaction rate of the transpeptidation. As this parameter is different for every protein, we recommend testing the substrates empirically with fluorescently labeled or biotinylated peptides before performing the reaction with the click handles. Design of a linker between the sortase A sequence (Gly n and/or LPXTG) and the protein may be required to enhance the extent of conversion and reaction rate. When the initial methionine is not removed by methionyl-aminopeptidase in the course of protein expression, a protease cleavage site, such as thrombin, tobacco etch virus (TEV), Factor Xa or a small ubiquitin-like modifier (SUMO) sequence, can be inserted upstream of the Gly n nucleophile to ensure a clean and active N terminus 21 . The optimized protein substrates and conditions can be used with no further modification in transpeptidation reactions with click handle-containing peptides.
Fusing proteins through click reaction. The final step of the procedure is fusing the click handle-containing proteins. These are the requirements for efficient fusion: the reaction must be fast; it should be bioorthogonal, as the reaction should only take place at the click handle; and the reaction conditions must be mild in order to prevent damage to the proteins. Furthermore, the click handles must be stable under a range of conditions. Cycloaddition reactions between an alkyne and azide fulfill most of these requirements.
Two major types of this bioorthogonal reaction have been reported: the copper (I)-catalyzed cycloaddition of terminal alkynes with azides 22, 23 and the strain-promoted cycloaddition of cyclooctynes with azides 24, 25 . The former reaction has been successfully applied in the preparation of many bioconjugates. For example, Caruso et al. 26 recently used the copper-catalyzed click reaction in combination with sortase A-mediated transpeptidation reaction to functionalize PEGylated capsules. In an analogous approach, Gupta et al. 27 used copper-catalyzed click chemistry in conjunction with sortase A-catalyzed reaction to produce protein dendrimers. One of the disadvantages of the copper-catalyzed click chemistry approach is that millimolar concentrations of copper (I) are required for the reaction to proceed, which may lead to oxidation of cysteine, methionine and histidine residues. Although a variety of ligands have been developed that minimize oxidation of proteins 28 , we opted to use strain-promoted cycloaddition reactions using cyclooctynes. These reagents make the use of copper obsolete. Mixing appropriate concentrations of the azide-containing protein and of the cyclooctyne-containing protein in a suitable buffer is sufficient to initiate the click reaction because of favorable reaction rates (rate constants of 0.3-0.9 M − 1 s − 1 have been reported for the most reactive cyclooctynes) 29 . The disadvantage of cyclooctyne-containing reagents is that they may react with thiols in a thio-yne reaction 19 . Despite this disadvantage, cyclooctynes in combination with azides have successfully been applied to the synthesis of protein fusions in several methods analogous to those described in this protocol 30, 31 . Purified target protein in buffer (no phosphate-based buffer). Protocols for the preparation of sortase A from S. aureus and for the N-and C-terminal labeling of proteins are described in detail in other protocols, Guimaraes et al. 6 and Theile et al. 18 Purified sortase A in buffer (no phosphate-based buffer) prepared as described 6 Oligoglycine peptides 1-3 (if creating C-to-C fused proteins) or LPETGG peptides 4 and 5 (if creating N-to-N fused proteins) stock solution: 10 mM in DMSO or water (10× stock) •
MaterIals

REAGENTS
• proceDure peptide synthesis 1| Synthesize the peptides for the N-or C-terminal sortagging reactions, respectively, depending on the modification (N or C terminus) that is required. The different peptides are described in the table below. ? trouBlesHootInG  pause poInt The crude product needs to be purified as soon as possible, but it can be stored as a solid at −20 °C for 1 week before purification. Lyophilize the peptide when storing the crude peptide for a longer period. (xx) Analyze the crude product by LC/MS. If LC/MS shows that the crude peptide is of sufficient purity, Step 1A(xxi-xxiii) may be omitted and the peptide may be used directly in sortase reactions. (xxi) HPLC purification. Re-dissolve the peptide in water (2 ml). tert-Butanol can be added to increase solubility. (xxii) Purify the peptide by reverse-phase HPLC on a Waters Delta Pak 15 µm, 100 Å C18 column (7.8 × 300 mm) using the following gradient: 25-34% B over three column-volumes. (xxiii) Lyophilize the purified peptides.
 pause poInt The purified lyophilized peptide can be stored at −20 °C indefinitely. (xxiv) Verify the identity and purity by LC/MS analysis (linear gradient 5-45% B in 10 min) and NMR spectroscopy. Note that probe 1 consists of a mixture of regioisomers. This mixture is separated by HPLC purification. Both regioisomers can be used in sortase A-catalyzed transacylation reactions.
(B) H 2 n-GGGK(azidohexanoic acid)-conH 2 (2) • tIMInG 2 d
(i) Solvate and load the rink amide resin (167 mg, 100 µmol) with Fmoc-Lys(Mtt)-OH (187 mg, 300 µmol) as described in
Step 1A(i-vii). (ii) Couple Fmoc-Gly-Gly-Gly-OH (123 mg, 300 µmol) by using the conditions described in Step 1A(iii-vii), except replacing Fmoc-Lys(Mtt)-OH with Fmoc-Gly-Gly-Gly-OH. (iii) Remove the Mtt-protecting group as described in Step 1A(x, xi).
(iv) Couple 6-azido-hexanoic acid (62 mg, 400 µmol) under the agency of PyBOP (208 mg, 400 µmol) and DIPEA (140 µl, 800 µmol) in NMP (4 ml). Agitate the reaction for 2 h at room temperature. D) 6-azido-hexanoyl lpetGG-conH 2 (4) • tIMInG 2-3 d (i) Solvate and load rink amide resin (167 mg, 100 µmol) with Fmoc-Gly-OH (99 mg, 300 µmol), as described in
Step 1A(i-vii). (ii) Elongate the peptide by repeating Step 1A(iii-vii) with Fmoc-Gly-OH (99 mg, 300 µmol), Fmoc-Thr(OtBu)-OH (119 mg, 300 µmol), Fmoc-Glu(OtBu)-OH (128 mg, 300 µmol), Fmoc-Pro-OH (101 mg, 300 µmol), Fmoc-Leu-OH (106 mg, 300 µmol) and 6-azido-hexanoic acid (47 mg, 300 µmol).  crItIcal step The Kaiser test does not work for the leucine coupling, as proline is a secondary amine. To test this coupling, one can perform a microcleavage (see Box 1 in Guimaraes et al. 6 ). (iii) Cleave the peptide from the resin by using the conditions described in Step 1A(xv-xix). (iv) Purify and lyophilize the peptide as described in Step 1A(xxi-xxiii) for peptide 1, but by using a gradient of 26  crItIcal step The peptide must be cleaved off the resin before introducing the DIBAC. The cleavage cocktail can cause a ring rearrangement reaction, which forms a product that does not perform a strainpromoted click reaction. (v) Dissolve the crude product in DMF (0.5 ml). Add DIBAC-OSu (14 mg, 20 µmol) and DIPEA (7 µl, 40 µmol), and incubate the reaction overnight at room temperature. (vi) Dilute the solution in 2 ml of 0.1% (vol/vol) aqueous TFA, and then purify and lyophilize it as described in
Step 1A(xxii, xxiii) of peptide 1 by using a gradient of 25-34% B in three column-volumes. (vii) Verify the identity and purity of 5 by LC/MS analysis (linear gradient 5-45% B in 10 min) and NMR spectroscopy.
 pause poInt The lyophilized peptide can be stored at −20 °C indefinitely.
preparation of sortase and the substrates • tIMInG 4-5 d 2| Prepare sortase A as described in Guimaraes et al. 6 .
3| Prepare the protein substrate containing either an N-terminal oligoglycine sequence or containing a C-terminal LPXTGG sequence as described in Guimaraes et al. 6 and Theile et al. 18 .
sortase-mediated transacylation reactions • tIMInG 1-2 d 4|
Introduce the click handles either at the N terminus or at the C terminus of the target protein using a sortase-mediated transacylation reaction. The site of labeling depends on the protein, and the table below shows the options.
4A N-terminal labeling using one of the peptides described in Step 1D or 1E 4B C-terminal labeling using one of the peptides described in Step 1A, B or C ? trouBlesHootInG (a) n-terminal sortagging (for proteins requiring their c terminus for activity) (i) Add sortase A of S. aureus (20-150 µM final concentration) and peptide 4 or 5 (0.5 mM final concentration) to GGG-protein (10-50 µM final concentration) in sortase buffer (1×).  crItIcal step For each substrate, the optimal labeling conditions (concentration of sortase, peptide and protein substrate, reaction time and reaction temperature) need to be determined empirically by varying these parameters and running a 1-µl aliquot on an SDS-PAGE gel and determining the conversion. See also Theile et al. 18 . (ii) Incubate the resulting mixture at room temperature or at 37 °C for 3-16 h, depending on the substrate. (iii) Add 500 µl of Ni-NTA resin pre-equilibrated in nickel-binding buffer to the reaction mixture and agitate it on an end-over-end shaker for 30 min at 4 °C to remove unreacted substrate and sortase A. Collect the supernatant by centrifuging at 280g for 5 min at 4 °C, and then wash the beads with an additional 500 µl of buffer.
 crItIcal step This step is optional and only required if the labeling reaction is incomplete and/or if the molecular weight of the protein substrate is similar to the molecular weight of sortase A.  crItIcal step This step only works if the product of the sortagging reaction does not contain a His-tag. (iv) Centrifuge the mixture at 16,873g for 10 min to remove any precipitate formed, and then purify the product on a Pharmacia Äkta Purifier system equipped with a Superdex 75 or a Superdex 200 size-exclusion column (depending on the molecular weight of the protein). The flow rate should be 1 ml min −1 , and the fraction size is 1.3 ml (with a HiLoad 16/60 size-exclusion column).  crItIcal step The resulting product must be purified before the click reaction. Excess of probe interferes with the click reaction. Other purification methods can be used (dialysis, desalting columns) for purification, but in our hands, size-exclusion chromatography performs best in terms of speed, yield and purity.  crItIcal step The addition of 10% (vol/vol) glycerol to the eluent may be beneficial for proteins that show a tendency to precipitate.  pause poInt The pure product can be stored in a buffered solution containing 10% (vol/vol) glycerol at −70 °C for several months and at 4 °C for several weeks (protein dependent).
(B) c-terminal sortagging (for proteins requiring their n terminus for activity).
(i) Add sortase A of S. aureus (150 µM final concentration) and peptide 1, 2 or 3 (0.5 mM final concentration) to the protein-LPETGGHHHHHH (15-50 µM final concentration) in sortase buffer (1×).  crItIcal step For each substrate, the optimal labeling conditions (concentration of sortase, peptide and protein substrate, reaction time and reaction temperature) need to be determined empirically by varying these parameters and running 1 µl on a SDS-PAGE gel and determining the conversion. See also Guimaraes et al. 6 . (ii) Incubate the resulting mixture for 3-16 h (depending on the substrate) at room temperature or at 37 °C. (iii) Purify the protein as described in Step 4A(iii-vi) of the N-terminal labeling.
 crItIcal step The sortase A reaction product must be purified before execution of the click reaction. Excess probe interferes with the click reaction. Other purification methods can be used (dialysis, desalting columns) for purification, in our hands, size-exclusion chromatography performs best in terms of speed, yield and purity.  crItIcal step Verify the identity and purity of the product by SDS-PAGE and by LC/MS analysis (linear gradient 5-45% B in 10 min).  pause poInt The pure product can be stored in a buffered solution containing 10% (vol/vol) glycerol at −70 °C for several months and at 4 °C for several weeks. 
7|
Centrifuge the mixture at 16,873g for 10 min to remove any precipitate formed.
8|
Apply the supernatant to a Pharmacia Äkta Purifier system equipped with a Superdex 75 or a Superdex 200 HR sizeexclusion column, depending on the molecular weight of the product. The flow rate is 0.4 ml min −1 , and the fraction size is 0.5 ml (with an HR 10/30 size-exclusion column).  crItIcal step The addition of 10% (vol/vol) glycerol to the eluent may be beneficial for proteins that show a tendency to precipitate.
9| Collect the peak fractions.
10| Concentrate the fractions in Amicon Ultra concentrators (Millipore).
11|
Analyze the identity and purity of the product by SDS-PAGE and by LC/MS (linear gradient 5-45% B in 10 min).  pause poInt The pure product can be stored in a buffered solution containing 10% (vol/vol) glycerol at −70 °C for several months and at 4 °C for several weeks.
? trouBlesHootInG Troubleshooting advice can be found in table 1. The cyclooctyne has been modified in
Step 1E or Step 4 Make sure that in the course of peptide synthesis, the cyclooctyne is introduced in the final step to prevent ring rearrangements Exclude the cyclooctyne from azides and/or minimize contact with thiols to prevent unwanted side reactions 19 . Freshly prepare cysteine-rich containing proteins
Precipitate forms during click reaction
Protein precipitates under the used reaction conditions
Lower the protein concentration (slows down the reaction). Lower the temperature to room temperature and increase the reaction time. Add 10% (vol/ vol) glycerol to proteins that prevent precipitation
Step 1E, synthesis of DIBAC-LPETGG-CONH 2 (5): 3-4 d
Step 2, expression of sortase A: 4-5 d
Step 3, expression of protein substrate: 4-5 d
Step 4, sortagging of the protein: 1-2 d
Steps 5-11, click reaction: 1-2 d
antIcIpateD results Precipitation after solid-phase peptide synthesis typically gives the crude peptides in reasonable yields and purity before purification. HPLC purification affords the peptides in yields of 50-80%, except for 6-azido-hexanoyl LPETGG-CONH 2 4, which was obtained in 22% yield. Concentrating the supernatant of the precipitation step, which was not done in this case, may increase the yield of 4. N-and C-terminal labeling using the click handle-containing peptides is comparable to sortagging reactions with other peptides (Fig. 3a) , and the labeling efficiency is typically >70%. In many cases, a product is obtained that migrates differently from the hydrolysis product and starting substrate on the SDS-PAGE gel. The labeling efficiency depends on the protein, and the exact conditions for the substrate should be determined empirically. The conditions given in this manuscript are a starting point for optimization, but they have generally produced good results. Optimal labeling can be achieved by varying the concentration of sortase (equimolar to tenfold excess), substrate and probe (0.5-1 mM), and by varying the reaction time (3-16 h) and temperature (15-37 °C) .
Mixing of the appropriate click handle-containing proteins (azide with cycloocytne) rapidly results in the formation of a product with a molecular weight corresponding to the combined molecular weight of the two starting proteins (Fig. 3b,c) . Conversion to the fusion protein is generally ~60-80% after 24 h as judged by SDS-PAGE, but it depends on the used proteins, and therefore the exact conditions (temperature and concentration) need to be established empirically. The concentration of the reagents determines both the reaction rate and yield. coMpetInG FInancIal Interests The authors declare competing financial interests: details are available in the online version of the paper.
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